ARD-2051

N/A

Report date: 2023/07/03 17:36:38
NME

Base Information

Drug NameARD-2051
Drug Alias NameARD-2051
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionAndrogen Receptor degraders
TargetsAndrogen Receptor
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of MichiganOncopia Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesOncopia Therapeutics IncUniversity Of Michigan
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A